Ic Targets Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IC TARGETS, and what generic and branded alternatives to IC TARGETS drugs are available?
IC TARGETS has one approved drug.
Summary for Ic Targets
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ic Targets
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ic Targets
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | 4,647,447 | ⤷ Sign Up |
| Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | 5,091,169 | ⤷ Sign Up |
| Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | 5,223,243 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
